
TSE:MFC
This summary was created by AI, based on 28 opinions in the last 12 months.
Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.
Has been coming to life lately. Newman management has done a good job at trying to decrease the sensitivity to equity markets and interest rates, but the exposure is still there. Because the economy globally is not picking up, central banks have felt the need to keep interest rates lower than they should be. She prefers staying in banks.
It is not moving up because of two things: equity prices and they are just not earnings the returns on the fixed income side of the portfolio. They are trying to do as much as they can to grow the business and are expanding there and it is becoming a much larger part of their earnings stream. He holds this rather than SLF, which he prefers.
Pretty much exactly the same as Sun Life (SLF-T) in that the dividend appears to be pretty safe. The one thing that is improving slightly is the probability of them doing a sizable acquisition (ING’s Asian insurance) on highly dilutive terms. Could face an actuarial review, so there could be a further write-down of $0.55 this quarter. Held hostage to bond yields.
Seasonal strength from Jan to April. Peruse this stock. It is already in an uptrend. Get into it at weakness. It is overbought right here. You want to hold it.